QXO

Cardiovascular Machine Learning-Based Notification Software

Product code
QXO
Device name
Cardiovascular Machine Learning-Based Notification Software
Device class
Class 2
21 CFR
21 CFR 870.2380
Medical specialty
Cardiovascular
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1
Summaries archived here
1 (direct download)
510(k) clearances (all years, FDA)
2 (all years; only the last 3 years are listed here)

FDA classification definition

Cardiovascular machine learning-based notification software employs machine learning techniques to suggest the likelihood of a cardiovascular disease or condition for further referral or diagnostic follow-up. The software identifies a single condition based on one or more non-invasive physiological inputs as part of routine medical care. It is intended as the basis for further testing and is not intended to provide diagnostic quality output. It is not intended to identify or detect arrhythmias.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-06-08.

NumberDecision dateApplicantDevice nameSummary
K2603322026-06-08Pathwai, Inc.EchoNextPDF

1 summaries are archived here for direct download.

Official FDA classification page: QXO
Classification and pathway per current FDA publications. Data from openFDA (CC0).